BNP Paribas’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$985 Hold
120
﹤0.01% 317
2026
Q1
$621 Hold
120
﹤0.01% 324
2025
Q4
$838 Hold
120
﹤0.01% 336
2025
Q3
$985 Hold
120
﹤0.01% 324
2025
Q2
$1.02K Buy
120
+119
+11,900% +$863 ﹤0.01% 332
2025
Q1
$931 Sell
1
-999
-100% -$10.1K ﹤0.01% 348
2024
Q4
$9.29K Buy
1,000
+860
+614% +$8.3K ﹤0.01% 332
2024
Q3
$1.18K Sell
140
-150
-52% -$1.24K ﹤0.01% 362
2024
Q2
$2.89K Hold
290
﹤0.01% 317
2024
Q1
$4.4K Buy
+290
New +$5.26K ﹤0.01% 317

Other funds holding TDOC

BNP Paribas's TDOC Position: Q2 2026 in Review

BNP Paribas held its Teladoc Health (TDOC) position steady in Q2 2026 at 120 shares worth $985. The position accounts for ﹤0.01% of the portfolio, ranked #317.

BNP Paribas first reported a position in TDOC in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.29K in Q4 2024. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • BNP Paribas held 120 shares of Teladoc Health worth $985 as of Q2 2026.
  • BNP Paribas left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of BNP Paribas's portfolio in Q2 2026, its #317 holding.
  • BNP Paribas first reported a position in Teladoc Health in Q1 2024 and has held it in 10 quarters since.
  • BNP Paribas's Teladoc Health position peaked at $9.29K in Q4 2024.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.